On the other hand, promising advances have been obtained, focused in the tau-related process to treat diverse tauopathies, highlighting inhibitors of tau and phosphorylated tau, stabilizers of microtubules, and tau anti-aggregating molecules [45]. This evidence concerns the gene MAPT and tauopathy.